Latest filing published 17 Mar 2016 for Endo International plc, €26k.
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by William Spengler span 5 companies, the busiest being Endo Pharmaceuticals Holdings Inc, MGI Pharma Inc and Endo International plc. We count 54 filings; the first trade dates from 9 May 2006 and the latest from 17 March 2016.
In open-market terms, that means 9 purchases worth €132k on one side and 1 sale worth €132k on the other. Netting one side against the other leaves €294 of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 35 share grants and 4 option exercises. 2016 to date brings 2 purchases and 1 sale.
Half of the purchases are above €11k and half below. Ninety days after publication, 6 purchases show a median change of -10.4%, with the price up in 33% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 17 March 2016, reports an open-market purchase of €26k in Endo International plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 54 declarations